Search | Clinical Trials Finder

Independent directory Public ClinicalTrials.gov records United States

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Sep 30, 2026, 8:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 54 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Lunesta (Eszopiclone) Clear all

Conditions: Primary Insomnia
Interventions: eszopiclone, placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 25 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Insomnia
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 65 Years to 85 Years
Enrollment: 388 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 82
States / cities: Birmingham, Alabama • Chandler, Arizona • Glendale, Arizona + 69 more

Conditions: Complex Insomnia
Interventions: eszopiclone, Brief behavioral therapy for insomnia; Drug · Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Obstructive Sleep Apnea
Interventions: Placebo, Acetazolamide, Trazodone, Atomoxetine and eszopiclone; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years to 70 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obstructive Sleep Apnea
Interventions: Lunesta, Placebo control; Drug
Lead sponsor: Walter Reed Army Medical Center; Federal
Eligibility: 18 Years to 64 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Depression, Anxiety, Insomnia
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sleep Apnea, Obstructive Sleep Apnea
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: North Haven, Connecticut

Conditions: Insomnia, Attention Deficit Hyperactivity Disorder
Interventions: eszopiclone; Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 89
States / cities: Tucson, Arizona • Little Rock, Arkansas • Carson, California + 70 more

Conditions: Acute Coronary Syndrome, Sleep Disorder
Interventions: Eszopiclone, Placebo; Drug · Other
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Insomnia
Interventions: Eszopiclone, Placebo, Escitalopram; Drug
Lead sponsor: Lehigh Center for Clinical Research; Other
Eligibility: 65 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Allentown, Pennsylvania

Conditions: Insomnia
Interventions: Trazodone, Eszopiclone, Placebo; Drug · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 673 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 35
States / cities: Birmingham, Alabama • Tuscaloosa, Alabama • Phoenix, Arizona + 31 more

Conditions: Obstructive Sleep Apnea
Interventions: Eszopiclone, Placebo control; Drug
Lead sponsor: Walter Reed Army Medical Center; Federal
Eligibility: 18 Years to 64 Years
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Obstructive Sleep Apnea
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 64 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Menopause, Insomnia
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 40 Years and older · Female only
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obstructive Sleep Apnea
Interventions: Acetazolamide 500 MG QHS, Eszopiclone 3 mg QHS; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 21 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Santa Monica, California • Westwood, Los Angeles, California

Conditions: Major Depressive Disorder, Insomnia
Interventions: escitalopram and eszopiclone, Escitalopram, eszopiclone, and placebo, Escitalopram; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 64 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: OSA, Obstructive Sleep Apnea
Interventions: Acetazolamide, Eszopiclone, Placebo, Venlafaxine; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: La Jolla, California

Conditions: Primary Insomnia
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 21 Years to 64 Years
Enrollment: 830 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 58
States / cities: Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 55 more

Conditions: Primary Insomnia
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 20 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Insomnia
Interventions: zolpidem tartrate; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Diabetes, Prediabetic, Prediabetes, Glucose Intolerance
Interventions: eszopiclone; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 64 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Marijuana Dependence
Interventions: eszopiclone, Placebo, ramelteon, zolpidem; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obstructive Sleep Apnea Syndrome
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 35 Years to 64 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 2
States / cities: Atlanta, Georgia • Cincinnati, Ohio

Conditions: Chronic Insomnia
Interventions: placebo, Zolpidem CR, Eszopiclone; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 65 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Detroit, Michigan